Cryo-Cell International (FRA:ZCY) Cyclically Adjusted PB Ratio: (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZCY Cryo-Cell International Inc FRA:ZCY
60 GF Score
Price €2.86
GF Value €4.33
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cryo-Cell International  (FRA:ZCY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cryo-Cell International Cyclically Adjusted PB Ratio Related Terms


Cryo-Cell International Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Cyclically Adjusted PB Ratio Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:ZCY vs EHSI, PIII, CCM: Cyclically Adjusted PB Ratio Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Cyclically Adjusted PB Ratio falls into.


FRA:ZCY
60GF Score
Cryo-Cell International Inc FRA:ZCY
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cryo-Cell International's Cyclically Adjusted Book per Share for the quarter that ended in May. 2026 is calculated as:

For example, Cryo-Cell International's adjusted Book Value per Share data for the three months ended in May. 2026 was:

Adj_Book=Book Value per Share/CPI of May. 2026 (Change)*Current CPI (May. 2026)
=-1.885/335.1230*335.1230
=-1.885

Current CPI (May. 2026) = 335.1230.

Cryo-Cell International Quarterly Data

Book Value per Share CPI Adj_Book
201608 -2.224 240.849 -3.095
201611 -2.104 241.353 -2.921
201702 -1.962 243.603 -2.699
201705 -1.820 244.733 -2.492
201708 -1.599 245.519 -2.183
201711 -1.500 246.669 -2.038
201802 -1.637 248.991 -2.203
201805 -1.640 251.588 -2.185
201808 -1.093 252.146 -1.453
201811 -1.005 252.038 -1.336
201902 -0.930 252.776 -1.233
201905 -0.927 256.092 -1.213
201908 -0.802 256.558 -1.048
201911 -0.838 257.208 -1.092
202002 -0.729 258.678 -0.944
202005 -0.605 256.394 -0.791
202008 -0.452 259.918 -0.583
202011 -0.299 260.229 -0.385
202102 -0.185 263.014 -0.236
202105 0.390 269.195 0.486
202108 0.478 273.567 0.586
202111 0.428 277.948 0.516
202202 0.441 283.716 0.521
202205 0.496 292.296 0.569
202208 -0.276 296.171 -0.312
202211 -0.176 297.711 -0.198
202302 -0.076 300.840 -0.085
202305 -0.095 304.127 -0.105
202308 -0.002 307.026 -0.002
202311 -1.230 307.051 -1.342
202402 -1.161 310.326 -1.254
202405 -1.232 314.069 -1.315
202408 -1.075 314.796 -1.144
202411 -1.540 315.493 -1.636
202502 -1.741 319.082 -1.829
202505 -1.712 321.465 -1.785
202508 -1.582 323.976 -1.636
202511 -1.998 324.122 -2.066
202602 -1.932 326.785 -1.981
202605 -1.885 335.123 -1.885

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.86 is trading 33.9% below its estimated GF Value™ of €4.33.

Key valuation signals for FRA:ZCY:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €4.33 vs. price of €2.86 (33.9% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
60GF Score

Get the complete analysis for FRA:ZCY

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.86
Price
€4.33
GF Value